visiting us at ASPHO 2021!
Dana-Farber/Boston Children's Cancer and Blood Disorders Center will showcase
their advances at the Annual Meeting of the American Society of Pediatric
Hematology Oncology (ASPHO).
Dana-Farber/Boston Children’s physicians will be presenting
View the schedule of speakers.
Our researchers and clinicians work together to bring the
most advanced tumor profiling techniques to children with cancer.
Learn more about our precision medicine clinical trials:
Recent precision medicine
Boston Children’s Gene
Therapy Program is one of the leading and largest gene therapy programs in
the world. Together, along with academic and pharmaceutical partners in the
U.S. and abroad, we have launched and participated in numerous clinical trials
for conditions including:
Recent gene therapy advances:
Dana-Farber/Boston Children's is a leader in developing
for a wide range of conditions. Our physicians work continuously to translate
laboratory findings into clinical therapies, including examining biological
therapies that help the body’s immune system fight cancer and lessen the
harmful side effects of some treatments.
Learn more about immunotherapy clinical trials
at Dana-Farber/Boston Children’s:
Cancer Genetic Risk
Cancer Genetic Risk Program provides cancer risk assessment for children,
comprehensive recommendations for managing cancer risk in children, and
psychosocial support for families affected by hereditary cancer. We also
conduct research into many aspects of cancer risk and its management.
Cancer and Blood Disorder Research Highlights
Stay informed about our clinical trials research efforts. Sign up for our email newsletter, Advances in Pediatric Hematology/Oncology.